tradingkey.logo

Treace Medical Concepts Inc

TMCI
2.260USD
+0.220+10.78%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
143.97MMarktkapitalisierung
VerlustKGV TTM

Treace Medical Concepts Inc

2.260
+0.220+10.78%

mehr Informationen über Treace Medical Concepts Inc Unternehmen

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Inc Informationen

BörsenkürzelTMCI
Name des UnternehmensTreace Medical Concepts Inc
IPO-datumApr 23, 2021
CEOTreace (John T)
Anzahl der mitarbeiter477
WertpapierartOrdinary Share
GeschäftsjahresendeApr 23
Addresse100 Palmetto Park Place
StadtPONTE VEDRA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32081
Telefon19043735940
Websitehttps://www.treace.com/
BörsenkürzelTMCI
IPO-datumApr 23, 2021
CEOTreace (John T)

Führungskräfte von Treace Medical Concepts Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+23917.00%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
378.40K
+316000.00%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
273.50K
+248505.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+23917.00%
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Ms. Jane E. Kiernan
Ms. Jane E. Kiernan
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+23917.00%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
378.40K
+316000.00%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
273.50K
+248505.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+23917.00%
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Treace (John T.)
18.72%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
3.57%
Andere
56.99%
Aktionäre
Aktionäre
Anteil
Treace (John T.)
18.72%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
3.57%
Andere
56.99%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
27.21%
Investment Advisor/Hedge Fund
22.63%
Hedge Fund
19.26%
Investment Advisor
15.78%
Research Firm
2.22%
Venture Capital
0.93%
Bank and Trust
0.32%
Pension Fund
0.04%
Family Office
0.03%
Andere
11.58%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
332
38.84M
60.95%
-15.62M
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Treace (John T.)
11.70M
18.37%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.32M
9.91%
+56.00K
+0.89%
Sep 30, 2025
William Blair Investment Management, LLC
3.63M
5.7%
+534.49K
+17.24%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.26M
5.11%
-26.43K
-0.80%
Sep 30, 2025
The Vanguard Group, Inc.
2.73M
4.29%
+6.24K
+0.23%
Sep 30, 2025
Gagnon Securities LLC
2.26M
3.54%
+8.09K
+0.36%
Sep 30, 2025
Treace (James T)
1.78M
2.79%
--
--
Mar 24, 2025
Millennium Management LLC
1.71M
2.68%
+192.93K
+12.72%
Sep 30, 2025
CIBC Private Wealth Management
1.69M
2.65%
-1.00K
-0.06%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
1.24M
1.94%
+330.87K
+36.44%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
Mehr Anzeigen
iShares U.S. Medical Devices ETF
Anteil0.04%
Franklin US Small Cap Multifactor Index ETF
Anteil0.04%
iShares Russell 2000 Growth ETF
Anteil0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
Fidelity Enhanced Small Cap ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
iShares Morningstar Small-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI